BENITIONSClinical Trial Intelligence

Diabetes Disparities: Texting to Extend Treatment (DD-TXT)

該当なし 完了 NCT04227379

対象疾患Diabetes Mellitus, Type 2
該当なし
スポンサーVA Office of Research and Development
ステータス完了
参加者数366 名
介入(薬剤)Intervention 1- DSMS+, Comparison - DSMS
開始日2023年1月30日
完了日2025年4月30日
結果公開日2026年6月1日

概要

One way to help Veterans improve their diabetes control is through the use of technology to help provide information, motivation, and reminders necessary to support diabetes self-management. The study will seek input from diverse groups of Veterans living with diabetes to help develop a new customizable, interactive texting intervention that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie for Veterans", a VA texting system for self-management support. Patients will be randomized to receive a once-daily standard diabetes self-management texting intervention called DSMS based on standard diabetes self-management education content or a customizable, patient-centered diabetes self-management support intervention with additional features called DSMS Plus (DSMS+) in order to test the comparative effectiveness of these two texting interventions.

Change in HbA1c Percent Time in Control

pre-enrollment, 6 month follow up · percent (%) of time in control

DSMS23.41 ± 34.96 percent (%) of time in control
DSMS+ (DSMS Plus)21.61 ± 40.55 percent (%) of time in control
p-value.6519
Mean Difference (Net)1.80 (95% CI -6.05–9.65)

Change in HbA1c

pre-enrollment, 6 month follow-up · Percentage of glycosylated hemoglobin

DSMS-0.36 ± 1.37 Percentage of glycosylated hemoglobin
DSMS+ (DSMS Plus)-0.40 ± 1.29 Percentage of glycosylated hemoglobin
p-value.7552
Mean Difference (Net).05 (95% CI -.25–.34)

BENITIONS で見る ClinicalTrials.gov の原文を見る

同じ疾患の他の治験

すべての治験

このページは ClinicalTrials.gov の公開データをまとめたものです。医学的助言ではなく、投資助言でもありません。必ず専門医にご相談ください。